| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.008 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |